Resmed (RMD) Shares Repurchased (2018 - 2025)
Resmed (RMD) has disclosed Shares Repurchased for 11 consecutive years, with $175.0 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Shares Repurchased rose 133.4% year-over-year to $175.0 million, compared with a TTM value of $500.1 million through Dec 2025, up 122.25%, and an annual FY2025 reading of $300.0 million, up 100.0% over the prior year.
- Shares Repurchased was $175.0 million for Q4 2025 at Resmed, up from $150.0 million in the prior quarter.
- Across five years, Shares Repurchased topped out at $175.0 million in Q4 2025 and bottomed at $50.0 million in Q1 2024.
- Average Shares Repurchased over 3 years is $86.1 million, with a median of $75.0 million recorded in 2024.
- The sharpest move saw Shares Repurchased skyrocketed 49.95% in 2024, then surged 199.99% in 2025.
- Year by year, Shares Repurchased stood at $50.0 million in 2023, then surged by 49.95% to $75.0 million in 2024, then surged by 133.4% to $175.0 million in 2025.
- Business Quant data shows Shares Repurchased for RMD at $175.0 million in Q4 2025, $150.0 million in Q3 2025, and $100.0 million in Q2 2025.